Global research community using genomic sequencing platform, running on Oracle Cloud Infrastructure (OCI), to discover and act on potentially harmful new coronavirus mutationsThe fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations.
Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent.
GPAS is also now part of the Public Health England New Variant Assessment Platform.The Global Pathogen Analysis System is being provided as a free resource to help combat COVID-19 and other microbial health threats.
Join the program and learn more at: www.gpas.cloudBuilt using Oxford’s Scalable Pathogen Pipeline Platform (SP3), Oracle APEX, and Oracle Cloud Infrastructure (OCI), the Global Pathogen Analysis System is a cloud platform that provides a unified, standardized system for analyzing and comparing the annotated genomic sequence data of SARS-CoV-2.
Researchers are using the system to upload pathogen data and receive comprehensive results within minutes.
Making this data comprehensible and shareable will help public health authorities evaluate and plan their response by giving them invaluable insight into emerging variants even before they are officially designated as Variants of Concern.Uniting the global research community in a common mission“GPAS is the first industry standards-based service anywhere in the world, offering a standardized sequence data analysis service for users on the cloud,” said Derrick Crook, professor of microbiology in the University of Oxford’s Nuffield Department of Medicine.
Global research community using genomic sequencing platform, running on Oracle Cloud Infrastructure (OCI), to discover and act on potentially harmful new coronavirus mutationsThe fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations.
Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent.
GPAS is also now part of the Public Health England New Variant Assessment Platform.The Global Pathogen Analysis System is being provided as a free resource to help combat COVID-19 and other microbial health threats.
Join the program and learn more at: www.gpas.cloudBuilt using Oxford’s Scalable Pathogen Pipeline Platform (SP3), Oracle APEX, and Oracle Cloud Infrastructure (OCI), the Global Pathogen Analysis System is a cloud platform that provides a unified, standardized system for analyzing and comparing the annotated genomic sequence data of SARS-CoV-2.
Researchers are using the system to upload pathogen data and receive comprehensive results within minutes.
Making this data comprehensible and shareable will help public health authorities evaluate and plan their response by giving them invaluable insight into emerging variants even before they are officially designated as Variants of Concern.Uniting the global research community in a common mission“GPAS is the first industry standards-based service anywhere in the world, offering a standardized sequence data analysis service for users on the cloud,” said Derrick Crook, professor of microbiology in the University of Oxford’s Nuffield Department of Medicine.